L04AA Selective immunosuppressants – page 2

ATC group of level 4 – chemical subgroup · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases

This site has the patient leaflet or the SPC of 115 medicines in this group and its subgroups.

Place in the ATC classification

How to read ATC codes – what the levels mean and what a code does not tell you.

L Antineoplastic and immunomodulating agents 1,791 medicines
1. L04 Immunosuppressants 545 medicines
  1. L04A Immunosuppressants 543 medicines
    1. L04AA Selective immunosuppressants 115 medicines
      1. L04AA03 antilymphocyte immunoglobulin (horse) 1 medicine
      2. L04AA04 antithymocyte immunoglobulin (rabbit) 1 medicine
      3. L04AA06 mycophenolic acid 26 medicines
      4. L04AA10 sirolimus 4 medicines
      5. L04AA13 leflunomide 18 medicines
      6. L04AA18 everolimus 3 medicines
      7. L04AA21 efalizumab 1 medicine
      8. L04AA23 natalizumab 2 medicines
      9. L04AA24 abatacept 5 medicines
      10. L04AA25 eculizumab 1 medicine
      11. L04AA26 belimumab 3 medicines
      12. L04AA27 fingolimod 12 medicines
      13. L04AA28 belatacept 1 medicine
      14. L04AA29 tofacitinib 3 medicines
      15. L04AA31 teriflunomide 1 medicine
      16. L04AA32 apremilast 10 medicines
      17. L04AA33 vedolizumab 3 medicines
      18. L04AA34 alemtuzumab 2 medicines
      19. L04AA36 ocrelizumab 1 medicine
      20. L04AA37 baricitinib 1 medicine
      21. L04AA38 ozanimod 3 medicines
      22. L04AA40 cladribine 2 medicines
      23. L04AA41 imlifidase 1 medicine
      24. L04AA42 siponimod 2 medicines
      25. L04AA43 ravulizumab 2 medicines
      26. L04AA44 upadacitinib 2 medicines
      27. L04AA45 filgotinib 2 medicines

8 more subgroups have no medicine with a leaflet on this site.

Medicines in the group and its subgroups

Medicine	Legal category
Rinvoq 30 mg prolonged-release tablets SPC (L04AA44 upadacitinib)	Prescription only (POM)
Saphnelo 300 mg concentrate for solution for infusion SPC	–
Soliris 300 mg concentrate for solution for infusion SPC (L04AA25 eculizumab)	Prescription only (POM)
Thymoglobuline 25 mg powder for solution for infusion SPC (L04AA04 antithymocyte immunoglobulin (rabbit))	Prescription only (POM)
Treatment Initiation Pack -, Apremilast 10 mg + 20 mg + 30 mg film-coated tablets SPC (L04AA32 apremilast)	–
Tysabri 150 mg solution for injection in Pre-filled syringe SPC (L04AA23 natalizumab)	Prescription only (POM)
Tysabri 300 mg concentrate for solution for infusion SPC (L04AA23 natalizumab)	Prescription only (POM)
Ultomiris SPC (L04AA43 ravulizumab)	Prescription only (POM)
Ultomiris 10 mg / ml concentrate for solution for infusion SPC no longer supplied (L04AA43 ravulizumab)	–
Xeljanz 1 mg / ml oral solution SPC (L04AA29 tofacitinib)	Prescription only (POM)
Xeljanz 10 mg film-coated tablets SPC (L04AA29 tofacitinib)	Prescription only (POM)
Xeljanz 11 mg prolonged-release tablets SPC (L04AA29 tofacitinib)	Prescription only (POM)
Zeposia SPC (L04AA38 ozanimod)	Prescription only (POM)
Zeposia 0.23 mg / 0.46 mg hard capsules SPC (L04AA38 ozanimod)	Prescription only (POM)
Zeposia 0.92 mg hard capsules SPC (L04AA38 ozanimod)	Prescription only (POM)

Sources

Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
World Health Organization (WHO): ATC/DDD classification, group L04AA

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.